Aphios Corporation

Aphios Corporation is a Delaware C corporation headquartered in Woburn, Massachusetts, specializing in biotechnology. Founded in 1993 by Dr. Trevor P. Castor who serves as President and CEO, the company is comprised of 11 employees. Aphios Corporation focuses on developing green, sustainable drug delivery platforms using biotechnology and nanotechnology. Their research is dedicated to creating enhanced therapeutic products for a variety of applications, including health maintenance, disease prevention, and treating cancers, infectious diseases, and Central Nervous System (CNS) disorders such as Alzheimer's Disease. The company's commitment to natural therapeutics stems from the belief that studying natural organisms that have mastered cellular control and longevity holds the key to solving complex diseases like cancer and aging. What distinguishes Aphios Corporation is its dedication to "viral safety" in biologics such as human plasma and recombinant therapeutics. The company's name, inspired by the Greek word for "virus-free," reflects this core principle. Aphios Corporation's research explores the vast potential of natural therapeutics derived from marine organisms and terrestrial plants, seeking to harness their unique properties for therapeutic applications. For more information, visit aphios.com.